SCHEMBL6380445

SCHEMBL6380445

NC(=O)N(Cc1ccn(-c2cc3nc(C(=O)O)c(=O)[nH]c3cc2Cl)c1)c1ccc(C(=O)O)cc1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GRIA1 P42261 5/20 0.45
GRIA2 P42262 5/20 0.45
GRIA3 P42263 5/20 0.45
GRIA4 P48058 5/20 0.45
GRIN2D O15399 2/20 0.45
GRIN3B O60391 2/20 0.45
GRIN1 Q05586 2/20 0.45
GRIN2A Q12879 2/20 0.45
GRIN2B Q13224 2/20 0.45
GRIN2C Q14957 2/20 0.45
GRIN3A Q8TCU5 2/20 0.45
LMNA P02545 1/20 0.45
GRIK1 P39086 1/20 0.45
GRIK2 Q13002 1/20 0.45
GRIK3 Q13003 1/20 0.45
GRIK4 Q16099 1/20 0.45
GRIK5 Q16478 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6381613 0.90 GRIN2D (0.42) GRIA1GRIA2GRIA3GRIA4GRIN2D
SCHEMBL6376950 0.90 GRIA1 (0.39) GRIA1GRIA2GRIA3GRIA4GRIN2D
SCHEMBL6380875 0.90 GRIA1 (0.40) GRIA1GRIA2GRIA3GRIA4GRIN2D
SCHEMBL6377603 0.88 GRIA1 (0.42) GRIA1GRIA2GRIA3GRIA4GRIN2D
SCHEMBL6375162 0.88 GRIA1 (0.39) GRIA1GRIA2GRIA3GRIA4GRIN2D
SCHEMBL6602742 0.88 GRIA1 (0.52) GRIA1GRIA2GRIA3GRIA4GRIK1
SCHEMBL6382607 0.86 GRIA1 (0.50) GRIA1GRIA2GRIA3GRIA4GRIN2D
SCHEMBL6377981 0.86 GRIA1 (0.40) GRIA1GRIA2GRIA3GRIA4GRIN2D
SCHEMBL6374724 0.84 GRIN2D (0.42) GRIA1GRIA2GRIA3GRIA4GRIN2D
SCHEMBL6601414 0.81 GRIA1 (0.46) GRIA1GRIA2GRIA3GRIA4GRIK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6632813-B1 6-subtituted-7-heteroquinoxalinecarboxylic acid derivatives and addition salts thereof and processes for the preparation of both KYORIN PHARMACEUTICAL CO., LTD. (JP) 2003-10-14 US claimed
EP-1156047-B1 6-SUBSTITUTED-7- HETEROQUINOXALINE CARBOXYLIC ACID DERIVATIVES AND ADDITION SALTS THEREOF AND PROCESSES FOR THE PREPARATION OF BOTH KYORIN SEIYAKU KK (JP) 2005-08-31 EP disclosed
US-6632813-B1 6-subtituted-7-heteroquinoxalinecarboxylic acid derivatives and addition salts thereof and processes for the preparation of both KYORIN PHARMACEUTICAL CO., LTD. (JP) 2003-10-14 US disclosed
EP-1156047-A1 6-SUBSTITUTED-7- HETEROQUINOXALINE CARBOXYLIC ACID DERIVATIVES AND ADDITION SALTS THEREOF AND PROCESSES FOR THE PREPARATION OF BOTH KYORIN PHARMACEUTICAL CO., LTD. (JP) 2001-11-21 EP disclosed